Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 169-174

  Morse, G D ^a   Fischl, M A ^a   Shelton, M J ^a   Cox, S R ^a   Driver, M ^a   Deremer, M ^a   Freimuth, W W ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DELAVIRDINE; DIDANOSINE; DRUG METABOLITE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEALKYLATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0031020802     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.169     Document Type: Article

References (30)